Abstract:The expression of EGLN2 gene was inhibited by the enrichment of YPA1 protein in EGLN2 promoter region after the transferring of YPA1 protein from cytoplasm to nucleus. EGLN2 protein promoted the degradation of HIF1‐α by polyubiquitination of HIF1‐α protein in cytoplasm. HIF1‐α, a regulator of anabolic glycolysis, promoted the transcription of a series of glycolytic gene expression, including GLUT1, Hk2 and LDHA, through binding to the hypoxia response element (HRE) of the target gene. Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases and has remarkably high mortality rates. In recent years, altered metabolism has been shown to contribute to the maintenance of pancreatic cancer malignancies. However, the molecular mechanism underlying glucose metabolism reprogramming remains elusive. The aim of this study was to elucidate the role of Yes‐associated protein (YAP1), an important effector of the Hippo pathway, in the regulation of aerobic glycolysis in pancreatic cancer. Moreover, the contributions of YAP1 and its associated glycolytic enzymes to prognosis were assessed via The Cancer Genome Atlas (TCGA) dataset. Methods YAP1 expression was silenced by short hairpin RNA (shRNA), and its effects on glycolytic activity and mitochondrial respiration were analysed via Agilent Seahorse XF Analysers. The effects of YAP1 on hypoxia‐inducible factor‐1α (HIF‐1α) and its transcriptional activity on glycolytic genes were examined via shRNA‐mediated silencing of YAP1. The underlying mechanism by which YAP1 controls the HIF‐1α protein level was analysed by exploring the interaction between YAP1 and egg‐laying‐defective nine family (EGLN) members, which are well‐established regulators of the HIF‐1α protein level. Finally, the effects of YAP1, EGLN and glycolytic genes on prognosis were analysed via TCGA dataset. Results We found that silencing YAP1 expression inhibited anabolic glycolysis in pancreatic cancer cells. YAP1 was demonstrated to regulate the HIF‐1α protein level, transcriptional activity and the expression of HIF‐1α‐targeted glycolytic genes. In‐depth analysis demonstrated that EGLN2, a modulator of the HIF‐1α protein level, was a direct target of YAP1. Low EGLN2 expression was associated with a poor prognosis. By analysing TCGA dataset and performing immunohistochemical staining, we demonstrated that YAP1 expression was negatively correlated with EGLN2 expression at the mRNA level and protein levels. Conclusions The present study demonstrated that YAP1 positively regulates aerobic glycolysis by inhibiting EGLN2 expression, which results in an increased HIF‐1α protein level and transcriptional activity. YAP1 was positively regulated and significantly correlated with HIF‐1α‐targeted glycolytic genes, including glucose transporter type 1(GLUT1), hexokinase2 (HK2) and lactate dehydrogenase A (LDHA). Elevated YAP1 expression and concomitant downregulation of EGLN2 contributed to poor survival in patients with pancreatic cancer. Our results suggest that YAP1 may be a promising predictive marker and treatment target for human pancreatic cancer.

Tubulin Alpha 1c Promotes Aerobic Glycolysis and Cell Growth Through Upregulation of Yes Association Protein Expression in Breast Cancer

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma Via Regulating the Cell Cycle

Oncogene TUBA1C Promotes Migration and Proliferation in Hepatocellular Carcinoma and Predicts a Poor Prognosis.

YAP Overexpression in Breast Cancer Cells Promotes Angiogenesis Through Activating YAP Signaling in Vascular Endothelial Cells

The oncogenic role of tubulin alpha-1c chain in human tumours

The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.

YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma

Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues

Tubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy

TUBA1C is a Potential New Prognostic Biomarker and Promotes Bladder Urothelial Carcinoma Progression by Regulating the Cell Cycle

Yap1 Promotes the Survival and Self-Renewal of Breast Tumor Initiating Cells Via Inhibiting Smad3 Signaling

TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment

YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells

YAP is a Critical Oncogene in Human Cholangiocarcinoma

Yes-associated Protein Expression in Paired Primary and Local Recurrent Breast Cancer and Its Clinical Significance

YAP/TAZ: a promising target for squamous cell carcinoma treatment

Yes-associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis.

YAP Increases Response to Trastuzumab in HER2-positive Breast Cancer by Enhancing P73-induced Apoptosis

YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo

Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress

A yes-associated protein 1-Notch1 positive feedback loop promotes breast cancer lung metastasis by attenuating the Bone morphogenetic protein 4-SMAD family member 1/5 signaling